The Association Between Body Composition and Chemotherapy‐Induced Toxicity in Pancreatic Cancer: A Systematic Review
This review highlights inconsistencies in body composition's role in predicting chemotherapy toxicities and outcomes in pancreatic cancer. Variability in study methodologies complicated comparisons. Standardising body composition analysis with attention to ethnic variations and treatment types is essential for refining personalised treatment strategies in pancreatic cancer.
Authors
- Julian Choi
- Michael S. Lam (ORCID: https://orcid.org/0000-0001-9670-0025)
- Evelyn Hutcheon
- Justin Yeung (ORCID: https://orcid.org/0000-0002-7230-149X)
- Xavier Morgan Schlicht (ORCID: https://orcid.org/0000-0002-3772-7516)
- Olivia Otto
Institutions
- The University of Melbourne (AU)
- Epworth Hospital (AU)
- Footscray Hospital (AU)
- Western Health (AU)
Publication Details
- Journal
- ANZ Journal of Surgery
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1111/ans.70380
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00